JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (5): 84-87.doi: 10.6040/j.issn.1671-7554.0.2016.094

Previous Articles     Next Articles

RbAp48 expression and its clinical significance in endometrial adenocarcinoma

WANG Ping1, CHEN Jing2, SHI Qing1, FU Yibing1   

  1. 1.Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;
    2. Department of Obstetrics and Gynecology, Hospital of Maternal and Child Health, Jinan 250001, Shandong, China
  • Received:2016-01-25 Online:2016-05-16 Published:2016-05-16

PDF (PC)

214

Abstract: Objective To explore RbAp48 expression and its significance in endometrial adenocarcinoma. Methods Specimens were collected from 72 cases of normal endometrium(21 in hyperplasia phase, 27 in secretory phase, 24 in menopause), 27 cases of atypical hyperplasia, and 52 cases of endometrial adenocarcinoma with varying degrees of differentiation. The RbAp48 expression was detected with immunohistochemical method. The relevance between RbAp48 expression and the clinicopathological features of endometrial adenocarcinoma was analyzed. Results The RbAp48 expression was higher in endometrial adenocarcinoma than in normal endometrium and atypical hyperplasia. It was related to the secretory phase, menopause and atypical hyperplasia(P<0.05), but not related to proliferative phase(P>0.05). Poorly differentiated endometrial adenocarcinomas expressed higher RbAp48 than highly differentiated ones. RbAp48 expression was related to FIGO staging, distant metastasis, progestin use, myometrial invasion, obesity and diabetes, but not related to age, menarche age, dysmenorrhea, BMI, metastasis of pelvic lymph node, and lymphvascular space involvement. Conclusion RbAp48 is expressed in normal endometrium, endometrial atypical hyperplasia and endometrial adenocarcinoma tissues. RbAp48 expression is up-regulated in endometrial adenocarcinoma tissues suggesting that it may play an important role in endometrial adenocarcinoma.

Key words: Endomertrial adenocarcinoma, Retinoblastoma-associated protein48, PcG protein, Retinoblastoma

CLC Number: 

  • R737.33
[1] Struhl G. A gene product required for correct initiation of segmental determination in drosophila[J]. Nature,1981, 293(5827):36-41.
[2] Qian YW, Wang YC, Hollingsworth RE, et al. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast[J]. Nature, 1993, 364(6438):648-652.
[3] Alejandra L, Genevieve A. Histone chaperones, a supporting role in the limelight[J]. Biochim Biophys Acta, 2004, 1677(1-3):3-11.
[4] Scuto A, Zhang H, Zhao H, et al. RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase[J]. Cancer Res, 2007, 67(21):10317-10324.
[5] Lai A, Lee JM, Yang WM, et al. RBP1 recruits both histone deacetylase-dependent and independent repression activities to retinoblastoma family proteins [J]. Mol Cell Biol, 1999, 19(10):6632-6641.
[6] Tsujii A, Miyamoto Y, Moriyama T, et al. Retinoblastoma-binding protein 4-regulated classical nuclear transport is involved in cellular senescence [J]. J Biol Chem, 2015, 290(49):29375-29388.
[7] Huang HJ, Lee CC, Chen CY. Lead discovery for alzheimer's disease related target protein RbAp48 from traditional chinese medicine[J]. Biomed Res Int, 2014, 2014(2014):764946-764959.
[8] Francesco P, Michele P, Gennaro C, et al. RbAp48 is a target of nuclear factor-κB activity in thyroid cancer [J]. J Clin Endocrinol Metab, 2007, 92(4):1458-1466.
[9] Hai S, Shuang-LX, Cheng L, et al. Genes encoding Pir51,Beclin 1,RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma [J]. World J Gastroenterol, 2004, 10(4):509-513.
[10] Fukuoka J, Fujii T, Shih JH, et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung caneer[J]. Clin Cancer Res, 2004, 10(13):4314-4324.
[11] Cui F, Zan X, Li Y, et al. Grifola frondosa glycoprotein GFG-3a arrests S phase, alters proteome, and induces apoptosis in human gastric cancer cells[J]. Nutr Cancer, 2016, 68(2):267-279.
[12] Kong L, Yu XP, Bai XH, et al. RbAp48 is a critical mediator controlling the transforming activity of human papillomavirus type 16 in cervical cancer[J]. J Biol Chem, 2007, 282(36):26381-26391.
[13] Zheng L, Tang W, Wei FH, et al. Radiation-inducible protein RbAp48 contributes to radiosensitivity of cervical cancer cells[J]. Gynecol Oncol, 2013, 130(3):601-608.
[14] 钟晶晶, 杨旭锐, 麦梅清, 等. 下调RbAp48表达可抑制人宫颈癌MS751细胞株的迁移侵袭能力[J]. 南方医科大学学报, 2015, 35(11):1564-1569. ZHONG Jingjing, YANG Xurui, MAI Meiqing, et al. Effect of RbAp48 knockdown on migration and invasion of human cervical cancer cell line MS751 in vitro[J]. Journal of Southern Medical University, 2015, 35(11):1564-1569.
[15] 张雯, 冯婷婷, 郑琳, 等. 重组腺病毒介导的RbAp48基因表达对人宫颈癌细胞生长、增殖的影响[J]. 山东大学学报(医学版), 2014, 52(4):13-17. ZHANG Wen, FENG Tingting, ZHENG Lin, et al. Effects of enhanced expression of RbAp48 mediated by recombinant adenovirus on proliferation and growth of cervical cancer cells[J]. Journal of Shandong University(Health Sciences), 2014, 52(4):13-17.
[16] Torres-Roca JF, Fulp WJ, Caudell JJ, et al. Integration of a radiosensitivity molecular signature into the assessment of local recurrence risk in breast cancer[J]. Int J Radiat Oncol Biol Phys, 2015, 93(3):631-638.
[17] Kitange GJ, Mladek AC, Schroeder MA, et al. Retinoblastoma binding protein 4 modulates temozolomide sensitivity in glioblastoma by regulating DNA repair proteins[J]. Cell Rep, 2016, 14(11):2587-2598.
[18] Amy L, Creekmore, Kjirsten A, et al. The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor ɑ mediated gene expression[J]. Mol Cell Endocrinol, 2008, 291(1-2):79-86.
[19] Francesco P, Michele P, Gennaro C, et al. RbAp48 is a target of nuclear factor-κB activity in thyroid cancer[J]. J Clin Endocrinol Metab, 2007, 92(4):1458-1466.
[1] ZHANG Ping1, LIU Fang2, LUAN Li1, MA Daoxin1, WANG Jianbo1, TAN Bingxu1, CHENG Yufeng1. Inhibiting effects of combinative treatment of retinoblastoma 94 with radiotherapy in a mouse xenograft model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 26-.
[2] . RNA interference inhibits VEGF expression in retinoblastoma cells: an experimental study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(7): 13-15.
[3] YANG Le, SHEN Jia-Quan, CHENG Yu-Hong. Expressions of p-STAT3， MMP-2 and VEGF in retinoblastoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(5): 113-116.
[4] CHENG Yu-hong,SHEN Jia-quan,TANG Xia. Expression of MMP-14 and EMMPRIN in retinoblastoma and their significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(4): 411-414.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd